510(k) Report

PMA · Approved

Approved

Wallstent Endoprosthesis

P980033PMAApproved Nov 16, 20011,201-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boston Scientific Corporation · QKJ Stent, Central Venous

Approved on Nov 16, 2001 through premarket approval, which rests on the device’s own clinical evidence after a 1,201-day review.

Decided
Nov 16, 2001
Review
1,201 days
Class
Class III
Product code
QKJ
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P980033 has 65 supplements since 2002: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2002: 32003: 52004: 32005: 22006: 12008: 12010: 12011: 32012: 92013: 122014: 12015: 12016: 32017: 22018: 22019: 42020: 32022: 32023: 22024: 32026: 1
2002high 12 (2013) · low 0 (2007)2026
View FIG. 1 as a table
YearSupplements approved
20023
20035
20043
20052
20061
20081
20101
20113
20129
201312
20141
20151
20163
20172
20182
20194
20203
20223
20232
20243
20261
FIG. 1 — Supplements to P980033, 2002–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QKJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All QKJ devices

QKJ Stent, Central Venous: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · QKJ

3in 2024

2008: 12010: 12011: 32012: 92013: 122014: 12015: 12016: 32017: 22018: 22019: 42020: 22022: 32023: 22024: 32026 (partial year): 1
2007high 12 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QKJ

Too few QKJ 510(k)s in any year since 2007 to give a median.

Recalls per year · QKJ

No recall names QKJ since 2007.

Adverse event reports per year · QKJ

1in 2022

2022: 1
2007high 1 (2022) · low 0 (2007)2025

MAUDE reports naming product code QKJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—00
20090—00
20101—00
20113—00
20129—00
201312—00
20141—00
20151—00
20163—00
20172—00
20182—00
20194—00
20202—00
20210—00
20223—01
20232—00
20243—00
20250—00
20261—0—
Cite this page

510(k) Report. “P980033: Wallstent Endoprosthesis.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P980033

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026